Cointime

Zymosense

company

About

Zymosense develops novel probes for onsite and throughput enzyme measurement.

  • 1 - 10

Highlights

Total Funding Amount
$256K
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Industries
Biotechnology
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

Zymosense provides automated aqueous two-phase extraction for low-cost and scalable sorting of chiral-pure single-walled carbon nanotubes and a proof-of-concept demonstration for automating the NIST-developed ATP system for separating chiral-pure single-walled carbon nanotubes, enabling different industries to get access to rapid evaluation, discovery, and design of new enzymes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$256K
Zymosense has raised a total of $256K in funding over 2 rounds. Their latest funding was raised on Jun 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2022 Grant — 1 Iowa G2M Accelerator — Detail
Nov 26, 2021 Grant $256K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Zymosense is funded by 2 investors. Iowa G2M Accelerator and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Iowa G2M Accelerator Yes Grant
National Science Foundation Yes Grant
Cointime
เนื้อหา
บริษัท